Hypothalamic dysfunction combined with decreased insulin receptors and altered mitochondrial bioenergetics in individuals with PWS30, 31, 32 may underlie the early increases in insulin secretion and subsequent hyperinsulinemia. This evidence concerns the gene INS and Hyperinsulinemia.